Plasma Pentraxin 3 Levels Do Not Predict Coronary Events but Reflect Metabolic Disorders in Patients with Coronary Artery Disease in the CARE Trial

Chronic inflammation closely associates with obesity, metabolic syndrome, diabetes mellitus, and atherosclerosis. Evidence indicates that the immunomodulator pentraxin 3 (PTX3) may serve as a biomarker of these cardiometabolic disorders, but whether PTX3 predicts cardiovascular complications is unkn...

Descripción completa

Detalles Bibliográficos
Autores principales: Miyazaki, Tetsuro, Chiuve, Stephanie, Sacks, Frank M., Ridker, Paul M., Libby, Peter, Aikawa, Masanori
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2014
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976379/
https://www.ncbi.nlm.nih.gov/pubmed/24705587
http://dx.doi.org/10.1371/journal.pone.0094073

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3976379/
https://www.ncbi.nlm.nih.gov/pubmed/24705587
http://dx.doi.org/10.1371/journal.pone.0094073

Ejemplares similares